JP Morgan Cazenove analysts initiated coverage on AstraZeneca PLC (NASDAQ:AZN) with a Overweight rating on January 15, 2026.
AstraZeneca PLC operates in the Healthcare sector. The stock currently trades at $94.43 with a market capitalization of $279,947,333,682.


